Use of 4D-CT for radiotherapy planning and reality in France: Data from a national survey
| Autor: | Elodie Guillaume, Sophie Espenel, Nicolas Magné, M. Baury, S. De Oliveira Duarte, S. Sotton, Amel Rehailia-Blanchard, Nicolas Vial, A. Vallard, C. Rancoule, M.Y. He, Jean-Baptiste Guy |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Stereotactic body radiation therapy medicine.medical_treatment Stereotactic radiation therapy Cancer Care Facilities Radiosurgery Hospitals Private Hospitals University Motion 03 medical and health sciences Imaging Three-Dimensional 0302 clinical medicine Neoplasms medicine Humans Radiology Nuclear Medicine and imaging Four-Dimensional Computed Tomography Lung cancer Radiation treatment planning Lung Radiology Department Hospital Hospitals Public business.industry Radiotherapy Planning Computer-Assisted Respiration General surgery medicine.disease Radiation therapy medicine.anatomical_structure Oncology Health Care Surveys 030220 oncology & carcinogenesis Hepatic irradiation France Lung tumours Artifacts business Procedures and Techniques Utilization |
| Zdroj: | Cancer/Radiothérapie. 23:395-400 |
| ISSN: | 1278-3218 |
| DOI: | 10.1016/j.canrad.2019.02.006 |
| Popis: | Purpose Lung and some digestive tumours move during a respiratory cycle. Four-dimensional scanography (4D-CT) is commonly used in treatment planning to account for respiratory motion. Although many French radiotherapy centres are now equipped, there are no guidelines on this subject to date. We wanted to draw up a description of the use of the 4D-CT for the treatment planning in France. Methods and material We conducted a survey in all French radiotherapy centres between March and April 2017. Results One hundred and seventy-two were contacted. The participation rate was 88.37%. The use of the 4D-CT seems to be common and concerned planning for 15.28% of kidney and adrenal cancers, 19.72% of pancreatic cancers, 27.78% of oesophageal cancers and 73.24% of lung cancers in case of normofractionated treatments. The use of the 4D-CT was also widespread in the case of stereotactic body radiation therapy: with 61.11% in the case of pulmonary irradiation and 34.72% in the case of hepatic irradiation. Many centres declared they carried out several 4D-CT for treatment planning (29, 55% in case of stereotactic body radiation therapy for lung tumours and 20% for liver tumours). Private centres tend to repeat 4D-CT more. Conclusion Although the use of the 4D-CT appears to be developing, it remains very heterogeneous. To date, the repetition of the 4D-CT has been very poorly studied and could be the subject of clinical studies, allowing to define in which indications and for which populations there is a real benefit. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect